Immunohistochemical Assessment of HER3 Expression in Pancreatic Cancer
Pancreatic cancer (PC) is one of the most lethal tumor malignancies, which has a poor prognosis and can be the cause of death despite tumor removal. New molecular investigations for therapeutic purposes have shown the expression of HER3 in pancreatic adenocarcinoma. Family receptors HER3 pl...
Saved in:
| Main Authors: | Hosnie Hoseini, Azade Sarani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Krupanidhi College of Pharmacy
2024-06-01
|
| Series: | Journal of Pharmaceutical Research |
| Online Access: | https://jopcr.com/articles/immunohistochemical-assessment-of-her3-expression-in-pancreatic-cancer |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population
by: Hosnie Hoseini, et al.
Published: (2024-11-01) -
Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy
by: Tomoyuki Satake, et al.
Published: (2024-12-01) -
Immunohistochemical Expression of ROS1 in invasive ductal carcinoma of breast in association with hormonal receptor status and Her2Neu expression
by: Muhammad Umair, et al.
Published: (2024-10-01) -
An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients
by: Athraa Falah Alshimerry
Published: (2025-01-01) -
HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd
by: Christian Fridolin Singer, et al.
Published: (2025-04-01)